Quick Results
Professional Photo
Professionals

Kevin N. Dietz Ph.D.

Patent Agent

Dr. Kevin Dietz is a registered patent agent in the Firm's New Orleans office and is also a member of the Firm's Intellectual Property Group.

Featured Videos

Patent Trial and Appeal Board Proceedings: Friend or Foe? April 23, 2018
Managing University Patents: Discussion of Legal Issues Commonly Faced by University Administrators June 20, 2017

Professional Biography

Overview

Dr. Dietz concentrates his practice on U.S. patent prosecution for life science and biotechnology fields, patent portfolio management and patentability assessment.

Prior to joining Baker Donelson, Dr. Dietz was with the Office of Technology Management at LSU Health Sciences Center New Orleans, where he focused on technology evaluation and marketing, patentability assessment and patent portfolio management.

Prior to joining LSU Health Sciences Center, Dr. Dietz completed a joint post-doctoral fellowship in the Department of Neurology at Harvard Medical School and the Center for Human Genetic Research at Massachusetts General Hospital, where he investigated the role of epigenetic modifications in Huntington's disease in the laboratory of Dr. James Gusella. He graduated from Louisiana State University with an undergraduate degree in Biology, and received a Ph.D. in Genetics from LSU Health Sciences Center.

Dr. Dietz's technical skills encompass genetics, biochemistry, molecular biology and cell biology. The author and co-author of several publications, he has also presented both oral presentations and posters at scientific meetings and conferences.

Professional Honors & Activities
  • Member – Association of University Technology Managers
    • Committee Member, Leadership Development Committee
    • Co-chair, Membership Development Committee
  • Member – Gulf Coast Intellectual Property Association
  • Recipient – 2015 AUTM Volunteer Service Award, Western Hemisphere
Representative Technologies
  • Antibodies, protein therapeutics, gene therapy, vaccines, RNA-based therapeutics, stem cell technologies, and treatments and diagnostics for cancer, neurodegenerative diseases, infectious diseases, ocular diseases and inflammation.
Publications
Speaking Engagements
  • "§101 Woes and Solution," Dana-Farber Cancer Institute, Boston, Massachusetts (November 2018)
  • "Intellectual Property: A Building Block to a Successful Business," Arkansas State University, Jonesboro, Arkansas (November 2018)
  • "Technology Commercialization: A synergy between Science, Business and Law," LSU Health Sciences Center (April 2018)
  • Responsible Conduct of Research Seminar on Intellectual Property, Pennington Biomedical Research Center (April 2018)
  • Moderator – "New to Tech Transfer?," 2018 AUTM Annual Meeting, Phoenix, Arizona (February 2018)
  • Moderator – Biotech & Cannabis Industry Panel, Turnaround Management Association of Louisiana (November 2017)
  • "Partnering with Universities and Industry," 2017 Louisiana Life Sciences and Technology Symposium, New Orleans, Louisiana (September 2017)
  • Moderator – "New to Tech Transfer?," 2017 AUTM Annual Meeting, Hollywood, Florida (March 2017)
  • "Cannabis and Its Medicinal Potential: State of the Research and Policy" (December 2016)
  • "Critical Issues in Licensing University Technologies," New Orleans BioInnovation Center (August 2016)
  • "University Patent Applications: To Be or Not To Be…a 'Micro Entity'," Network of Technology Transfer Professionals of Louisiana (NTTPL) (July 2016)

Industries

Education

  • Harvard Medical School, Department of Neurology; Massachusetts General Hospital, Center for Human Genetics Research
    • Research Fellow, 2010 – 2013
  • LSU Health Sciences Center New Orleans, Ph.D. in Genetics, 2010
  • Louisiana State University, BS in Biology, 2005

Admissions

  • United States Patent and Trademark Agent, Registration Number 73,511

Email Disclaimer

NOTICE: The mailing of this email is not intended to create, and receipt of it does not constitute an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.
Cancel Accept